Photothermal Effect Enhanced Cascade-Targeting Strategy for Improved Pancreatic Cancer Therapy by Gold Nanoshell@Mesoporous Silica Nanorod
Related Experiment Video
Updated: Aug 5, 2026

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
Ruifang Zhao1,2,3, Xuexiang Han1,2,3, Yiye Li1,3
1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center of Excellence in Nanoscience, National Center for Nanoscience and Technology , Beijing 100190, P. R. China.
Abstract:
Pancreatic cancer, one of the leading causes of cancer-related mortality, is characterized by desmoplasia and hypovascular cancerous tissue, with a 5 year survival rate of <8%. To overcome the severe resistance of pancreatic cancer to conventional therapies, we synthesized gold nanoshell-coated rod-like mesoporous silica (GNRS) nanoparticles which integrated cascade tumor targeting (mediated by photothermal effect and molecular receptor binding) and photothermal treatment-enhanced gemcitabine chemotherapy, under mild near-infrared laser irradiation condition. GNRS significantly improved gemcitabine penetration and accumulation in tumor tissues, thus destroying the dense stroma barrier of pancreatic cancer and reinforcing chemosensitivity in mice. Our current findings strongly support the notion that further development of this integrated plasmonic photothermal strategy may represent a promising translational nanoformulation for effective treatment of pancreatic cancer with integral cascade tumor targeting strategy and enhanced drug delivery efficacy.
Insights
Gold nanoshell-coated rod-like mesoporous silica (GNRS) nanoparticles enhance gemcitabine chemotherapy for pancreatic cancer. This novel nanoformulation overcomes treatment resistance by improving drug delivery and tumor targeting.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Pancreatic cancer has a high mortality rate due to treatment resistance.
- Desmoplasia and hypovascularity contribute to poor therapeutic outcomes.
- Conventional therapies show limited efficacy, with a 5-year survival rate below 8%.
Purpose of the Study:
- To develop an integrated nanoformulation for enhanced pancreatic cancer treatment.
- To combine cascade tumor targeting and photothermal treatment-enhanced chemotherapy.
- To overcome the dense stroma barrier and improve gemcitabine delivery.
Main Methods:
- Synthesis of gold nanoshell-coated rod-like mesoporous silica (GNRS) nanoparticles.
- Integration of photothermal effect and molecular receptor binding for tumor targeting.
- Application of mild near-infrared laser irradiation for photothermal therapy and drug release.
- Evaluation of gemcitabine penetration, accumulation, and therapeutic efficacy in preclinical models.
Main Results:
- GNRS nanoparticles demonstrated effective cascade tumor targeting.
- The photothermal effect enhanced gemcitabine penetration and accumulation in tumor tissues.
- The dense stroma barrier of pancreatic cancer was disrupted.
- Chemosensitivity was significantly reinforced in treated mice.
Conclusions:
- The integrated plasmonic photothermal strategy shows promise for pancreatic cancer treatment.
- GNRS nanoparticles offer enhanced drug delivery efficacy and overcome therapeutic resistance.
- This nanoformulation represents a potential translational approach for effective pancreatic cancer therapy.
More Related Videos
06:42Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution
Published on: May 9, 2025
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025